CPAP does not reduce inflammatory biomarkers in patients with coronary artery disease and nonsleepy obstructive sleep apnea: a randomized controlled trial
E Thunström, H Glantz, T Yucel-Lindberg, K Lindberg… - Sleep, 2017
Abstract Objectives Obstructive sleep apnea (OSA) and enhanced vascular inflammation
coexist in patients with coronary artery disease (CAD). Continuous positive airway pressure
(CPAP) is first-line treatment for OSA with daytime sleepiness. This analysis of data from the
coexist in patients with coronary artery disease (CAD). Continuous positive airway pressure
(CPAP) is first-line treatment for OSA with daytime sleepiness. This analysis of data from the
 |  |  |
Blood pressure response to CPAP treatment in subjects with obstructive sleep apnoea: the predictive value of 24-h ambulatory blood pressure monitoring
AL Castro-Grattoni, G Torres, M Martínez-Alonso… - European Respiratory …, 2017
The reduction in blood pressure (BP) with continuous positive airway pressure (CPAP) is
modest and highly variable. In this study, we identified the variables that predict BP
response to CPAP. 24-h ambulatory BP monitoring (ABPM), C-reactive protein (CRP), leptin,
modest and highly variable. In this study, we identified the variables that predict BP
response to CPAP. 24-h ambulatory BP monitoring (ABPM), C-reactive protein (CRP), leptin,
| | |
Autoadjusted versus fixed CPAP for obstructive sleep apnoea: a multicentre, randomised equivalence trial
KE Bloch, F Huber, M Furian, TD Latshang… - Thorax, 2017
Background The obstructive sleep apnoea syndrome (OSAS) is conventionally treated by
continuous positive airway pressure set at a fixed level (fCPAP). Automatic mask pressure
adjustment (autoCPAP) is increasingly used during home therapy. We investigated whether
continuous positive airway pressure set at a fixed level (fCPAP). Automatic mask pressure
adjustment (autoCPAP) is increasingly used during home therapy. We investigated whether
| | |
Global cognitive profile and different components of reaction times in obstructive sleep apnea syndrome: Effects of continuous positive airway pressure over time
M Devita, A Zangrossi, M Marvisi, P Merlo, ML Rusconi… - International Journal of …, 2017
... Performances of OSAS patients treated with CPAP and those of healthy controls are similar; • CPAP
plays an important role by slowing down the deleterious effects of OSAS, and by fostering a
sufficient cognitive functioning and an adequate motor speed. Abstract. ...
plays an important role by slowing down the deleterious effects of OSAS, and by fostering a
sufficient cognitive functioning and an adequate motor speed. Abstract. ...
| | |
[PDF] Hypertension, Obstructive Sleep Apnea, and CPAP: A Literature Review
T Doctorian, D Hwang - 2017
ABSTRACT Cardiovascular Disease (CVD) is the leading cause of mortality and morbidity
worldwide. Obstructive Sleep Apnea (OSA) remains an under diagnosed yet important risk
factor for CVD and adverse cardiovascular out comes. There is a known link between
worldwide. Obstructive Sleep Apnea (OSA) remains an under diagnosed yet important risk
factor for CVD and adverse cardiovascular out comes. There is a known link between
| | |
Management of hypertension in obstructive sleep apnoea: predicting blood pressure reduction under continuous positive airway pressure
R Tamisier, P Lévy - 2017
| | |
[HTML] Sex Differences in the Risk of Incident Hypertension With Sleep Apnea: Does Postmenopausal Status Matter?
JR Carter, B Mokhlesi - 2017
... Available online 6 October 2017. S0012369217303690. FOR RELATED ARTICLE SEE PAGE
742. Most meta-analyses of randomized controlled trials of CPAP therapy in patients with OSA
have reported significant, albeit small (about 2-3 mm Hg), reductions of BP after CPAP. ...
742. Most meta-analyses of randomized controlled trials of CPAP therapy in patients with OSA
have reported significant, albeit small (about 2-3 mm Hg), reductions of BP after CPAP. ...
| | |
[PDF] Comparison of Risperidone and Melatonin Effects in Methylphenidate Treated Children with Attention Deficit Hyperactivity Disorder for Treatment of Sleep Disorders
GF Damian, JM Gharaie, P Sabzali, F Darabi… - J Sleep Disord Ther, 2017
... in patients with moderate to severe sleep-disordered breathing (SDB) [6]. It is significantly
correlated with cardiovascular morbidity and mortality [7,8]. For patients with moderate to severe
OSAHS, standard treatment is the continuous positive airway pressure (CPAP) ventilation. ...
correlated with cardiovascular morbidity and mortality [7,8]. For patients with moderate to severe
OSAHS, standard treatment is the continuous positive airway pressure (CPAP) ventilation. ...
| | |
SYSTEM AND METHOD FOR TREATING OBSTRUCTIVE SLEEP APNEA
FA Papay - US Patent 20,170,274,210, 2017
... Continuous positive airway pressure (CPAP) is a standard treatment for OSA. While CPAP
is non-invasive and highly effective, it is not well tolerated by patients. Patient compliance
for CPAP is often reported to be between 40% and 60%. ...
is non-invasive and highly effective, it is not well tolerated by patients. Patient compliance
for CPAP is often reported to be between 40% and 60%. ...
| | |
[PDF] Differences in three-dimensional craniofacial anatomy between responders and non-responders to mandibular advancement device therapy in obstructive sleep …
H Chen - Three-dimensional analysis of the upper airway in …, 2017
... space and an increase in upper airway collapsibility [1]. Mandibular advancement splints (MAD)
are indicated for patients with mild to moderate OSA and in patients with severe OSA that refuse
or are unable to tolerate continuous positive airway pressure (CPAP) therapy [2-5 ...
are indicated for patients with mild to moderate OSA and in patients with severe OSA that refuse
or are unable to tolerate continuous positive airway pressure (CPAP) therapy [2-5 ...
| | |
Αυτή η Ειδοποίηση του Μελετητή Google σας προσφέρεται από τη Google
Ακύρωση ειδοποίησης
Δημιουργία λίστας των ειδοποιήσεών μου
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου